BHSRX

BlackRock Health Sciences Opps R
NasdaqUSDETF / FUND DELAYED
Last price
60.63
▲ 0.50 (0.83%)
MARKET · —

Price

1D — H — L — Range — Vol —
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
60.13
Day high
—
Day low
—
Volume
—
Market cap
—
P/E (TTM)
31.73
52W range
57.51 – 66.77

Trailing performance

Price return · vs SPY
Returnvs SPY
1W
-2.89% -4.8%
1M
-3.09% -4.6%
3M
-8.82% -12.2%
6M
+2.04% -12.9%
YTD
-3.05% -17.0%
1Y
-0.07% -15.8%
3Y
-1.30% -83.2%
5Y
— —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Top holdings

10 shown · by weight
SymbolNameWeight
LLY Eli Lilly and Co 11.92%
JNJ Johnson & Johnson 8.03%
MRK Merck & Co Inc 5.56%
ABBV AbbVie Inc 5.07%
TMO Thermo Fisher Scientific Inc 4.41%
UNH UnitedHealth Group Inc 4.33%
GILD Gilead Sciences Inc 4.09%
AMGN Amgen Inc 3.98%
VRTX Vertex Pharmaceuticals Inc 3.33%
ABT Abbott Laboratories 2.61%

Sector exposure

Fund weightings
Healthcare
100.00%

Fund profile

As reported
Fund familyBlackRock
CategoryHealth
Legal type—
Expense ratio1.47%
Turnover—
Total net assets—

Unusual options activity

Account required
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
Free account required

Contracts trading at or above their open interest, ranked by notional and where the print landed.

Free account

5 more panels on BHSRX open with an account.

Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.

Fundamentals

TTM · reported
Market cap—
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—

Valuation & profitability ratios

Account required
Trailing P/E31.73
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Options analytics

Account required
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—

Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.

Free account required

Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.

Analyst targets & ownership

Account required
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
Consensus—
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Free account required

Price targets, consensus spread, insider and institutional ownership.

Moving averages & technicals

Computed from 2Y daily closes
SMA 10
61.08
-0.74% from price
SMA 20
60.89
-1.25% from price
SMA 50
61.01
-1.45% from price
SMA 100
61.36
-1.18% from price
SMA 200
61.12
-1.61% from price
EMA 12
60.87
-0.40% from price
EMA 26
61.11
-0.78% from price
EMA 50
61.24
-0.99% from price
RSI (14)
41.6
Neutral
MACD (12,26,9)
-0.24
Hist -0.13
ATR (14)
0.43
0.71% of price
Realised vol 30D
13.2%
Annualised
Bollinger upper
62.30
20, 2σ
Bollinger lower
59.48
20, 2σ
50 / 200 cross
Death
61.01 vs 61.12
Trend bias
Below 200
-1.61%

Options chain

Account required
Expiry
Spot 60.63
Calls
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Puts
StrikeLastBidAskVolOIIV
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
000.000.000.000.00000.0%
Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Risk profile

Daily returns · 1Y window
Beta vs SPY
0.00
Less volatile than market
Correlation to SPY
0.00
Largely independent
Realised vol 30D
13.2%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-13.7%
Peak to trough
Max drawdown 5Y
-29.7%
Peak to trough
ATR 14
0.43
0.71% of price
Beta (reported)
—
5Y monthly, from filing

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.